- Home
- GERN vs UAN Comparison
GERN vs UAN Comparison
Compare GERN & UAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- UAN
- Stock Information
- Founded
- GERN 1990
- UAN 2007
- Country
- GERN United States
- UAN United States
- Employees
- GERN 229
- UAN N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- UAN Agricultural Chemicals
- Sector
- GERN Health Care
- UAN Industrials
- Exchange
- GERN Nasdaq
- UAN Nasdaq
- Market Cap
- GERN 823.0M
- UAN 943.7M
- IPO Year
- GERN 1996
- UAN 2011
- Fundamental
- Price
- GERN $1.30
- UAN $87.38
- Analyst Decision
- GERN Buy
- UAN
- Analyst Count
- GERN 8
- UAN 0
- Target Price
- GERN $3.71
- UAN N/A
- AVG Volume (30 Days)
- GERN 6.6M
- UAN 16.3K
- Earning Date
- GERN 11-06-2025
- UAN 10-27-2025
- Dividend Yield
- GERN N/A
- UAN 7.81%
- EPS Growth
- GERN N/A
- UAN 77.68
- EPS
- GERN N/A
- UAN 8.32
- Revenue
- GERN $164,447,000.00
- UAN $576,184,000.00
- Revenue This Year
- GERN $175.15
- UAN N/A
- Revenue Next Year
- GERN $56.61
- UAN N/A
- P/E Ratio
- GERN N/A
- UAN $10.26
- Revenue Growth
- GERN 11877.20
- UAN 8.15
- 52 Week Low
- GERN $1.09
- UAN $62.94
- 52 Week High
- GERN $4.83
- UAN $98.99
- Technical
- Relative Strength Index (RSI)
- GERN 42.28
- UAN 43.43
- Support Level
- GERN $1.27
- UAN $84.13
- Resistance Level
- GERN $1.52
- UAN $90.70
- Average True Range (ATR)
- GERN 0.06
- UAN 1.63
- MACD
- GERN -0.02
- UAN -0.35
- Stochastic Oscillator
- GERN 8.00
- UAN 49.15
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.